Description
Recombinant monoclonal antibody to PD-L2. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 24F.10C12. This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.
Target
PD-L2
Target Alias Names
CD273, PDL2, PDCD1LG2, PDCD1L2, PD-1 ligand 2, PDCD1 ligand 2, PDCD1 ligand 2, Programmed cell death 1 ligand 2, Butyrophilin B7-DC, B7-DC
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression